Year |
Funding Sources |
# Travel Grants Applications |
# Travel Grants Awarded |
Total # Advocate Registration to SABCS® |
1998 |
Glaxo Wellcome Eli Lilly Zeneca |
14 |
14 |
82 |
1999 |
Bristol-Myers Genentech Wyeth-Ayerst |
42 |
30 |
104 |
2000 |
Aventis Genentech AstraZeneca Glaxo Wellcome Pharmacia Oncology |
62 |
50 |
123 |
2001 |
AstraZeneca Aventis Bristol-Meyers Squibb Chroma Vision Eli Lilly Genentech GlaxoSmithKline Pharmacia |
52 |
36 |
118 |
2002 |
AstraZeneca Aventis Bristol-Myers Squibb ChromaVision DakoCytomation Eli Lilly Genentech GlaxoSmithKline Pharmacia |
40 |
28 |
119 |
2003 |
AstraZeneca Pharmaceuticals Bristol Myers Squibb Chromavision DakoCytomation Eli Lilly & Co Genentech Genomic Health GlaxoSmithKline Pfizer |
52 |
37 |
168 |
2004 |
AstraZeneca Pharmaceuticals DakoCytomatic, Inc. Genentech, Inc. Genomic Health, Inc. GlaxoSmithKline Introgen Therapeutics, Inc. Sanofi-Aventis |
52 |
37 |
168 |
2005 |
AstraZeneca Pharmaceuticals Cytyc Eli Lilly & Company Genentech Genomic Health GlaxoSmithKline Introgen Therapeutics Sanofi-Aventis |
49 |
32 |
201 |
2006 |
Avon Foundation NBCC Fund--Best Practices Award AstraZeneca Genentech Genomic Health Eli Lilly Sanofi-Aventis |
109 |
43 |
199 |
2007 |
Abraxis Oncology AstraZeneca Avon Foundation Genentech GlaxoSmithKline Novartis Roche Introgen Therapeutics Sanofi-Aventis Dr. Sharon Wilks |
109 |
42 |
233 |
2008 |
Abraxane-AZ AstraZeneca Avon Foundation Cytori Genentech BioOncology Genomic Health, Inc. GlaxoSmithKline Her2 Support Novartis Roche Sanofi-Aventis Dr. Sharon Wilks |
34 |
32 |
225 |
2009 |
Abraxis BioOncology AstraZeneca Avon Foundation for Women Cytori Therapeutics, Inc Eli Lilly & Co Genentech Genomic Health, Inc GlaxoSmithKline Her2 Support Group Organization National Breast Cancer Coalition Novartis Pharmaceuticals Corp Sanofi-Aventis Dr. Sharon Wilks, MD, FACP Dr. Peter Ravdin, MD, PhD |
82 |
36 |
235 |
2010 |
AACR Abraxis BioOncology Amgen AstraZeneca Avon Foundation for Women Eisai, Inc. Eli Lilly & Co. Genentech GlaxoSmithKline Novartis Pharmaceuticals Corporation Dr. Peter Ravdin, MD, PhD Sanofi-Aventis Dr Sharon Wilks, MD, FACP |
107 |
32 |
297 |
2011 |
AACR Amgen Avon Foundation for Women
Boehringer Ingelheim Genentech
Genomic Health, Inc. GlaxoSmithKline
Julie Ann Carpenter Memorial Fund
Novartis Pharmaceuticals Corp
Peter Ravdin, MD, PhD
Sharon Wilks, MD, FACP Syndax |
119 |
41 |
298 |
2012 |
AACR Amgen Avon Foundation for Women
Celgene Corporation Genentech
Genomic Health, Inc GlaxoSmithKline
Julie Ann Carpenter Memorial Fund
Nektar Novartis Pharmaceuticals Corp
Peter Ravdin, MD, PhD |
68 |
31 |
144 |
2013 |
AACR Amgen AstraZeneca
Avon Foundation for Women
Celgene Corporation Genentech
Genomic Health
Julie Ann Carpenter Memorial Fund
Novartis Pharmaceuticals
Peter Ravdin, MD, PhD SABCS®
Sharon Wilks, MD, FACP |
61 |
23 |
171 |
2014 |
AACR Amgen AstraZeneca
Avon Foundation for Women
DARA BioSciences Eisai Genentech
Genomic Health, Inc
Julie Ann Carpenter Memorial Fund
NanoString Technologies
Nektar Therapeutics
Novartis Pharmaceuticals
Nuclea Diagnostics Peter Ravdin, MD, PhD Pfizer SABCS® Syndax |
78 |
28 |
229 |
2015 |
AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Eisai Inc. Genentech BioOncology
Genomic Health, Inc. Julie Ann Carpenter Memorial Fund
NanoString Technologies Navidea Biopharmaceuticals Nektar Therapeutics Novartis Oncology Recycledman Foundation SABCS® Susan G. Komen Syndax Pharmaceuticals |
71 |
28 |
196 |
2016 |
AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Biotheranostics, Inc. Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Julie Ann
Carpenter Memorial Fund Lumicell
M-3 Health Communications NanoString Technologies
Nektar Therapeutics Novartis Oncology Pfizer The
Recycledman Foundation Syndax Pharmaceuticals SABCS® Susan G. Komen |
63 |
34 |
180 |
2017 |
AACR Avon Foundation for Women Biotheranostics, Inc. The Joe W. and Dorothy Dorsett Brown Foundation Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Immunomedics Julie Ann Carpenter Memorial Fund Merck NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer, Inc. The Recycled Man Foundation Seno Medical Instruments, Inc. Syndax Pharmaceuticals, Inc. |
73 |
31 |
222 |
2018 |
AACR Arcus BioSciences Biotheranostics, Inc Joe W and Dorothy Dorsett Brown Foundation Celgene Eisai Elekta Genentech Bio Oncology Genomic Health, Inc Julie Ann Carpenter Memorial Fund Merck & Co Inc NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer, Inc the Recycledman Foundation San Antonio Breast Cancer Symposium (in kind) Seattle Genetics Seno Medical Instruments, Inc Syndax Pharmaceuticals, Inc Theresa's Foundation |
61 |
25 |
163 |
2019 |
Agendia
AACR SSP
The Joe W and Dorothy Dorsett Brown
Foundation
Eisai, Inc
Genentech BioOncology
Genomic Health
Julie Ann Carpenter Memorial Fund
Mylan
Nektar Therapeutics
Novartis Oncology
Pfizer, Inc
The Recycled Man Foundation Sanofi-Genzyme
San Antonio Breast Cancer Symposium (in kind) Seattle Genetics
Syndax Pharmaceuticals
Theresa's Foundation
VisionRT
|
57 |
26 |
248 |
2020 |
N/A |
N/A |
N/A |
348 |
2021 |
N/A |
N/A |
N/A |
304 |